Akari Therapeutics (AKTX) Treasury Shares (2022 - 2025)

Akari Therapeutics (AKTX) has reported Treasury Shares for 4 consecutive years, with $1465.0 the latest figure, recorded in Q4 2025.

• Quarterly Treasury Shares changed N/A year-over-year to $1465.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1465.0 (changed N/A YoY) and the FY2025 annual result came in at $1465.0, changed N/A from the prior year.
• Treasury Shares fell to $1465.0 in Q4 2025 per AKTX's latest filing, from $251.8 million in the prior quarter.
• Over the last five years, Treasury Shares for AKTX reached as high as $418.6 million in Q2 2023 and fell as low as $1465.0 in Q4 2025.
• A 4-year average of $204.9 million and a median of $251.8 million in 2024 frame the typical range for Treasury Shares.
• Annual changes were most pronounced in 2023 — Treasury Shares surged 1849.12% — and 2024, when it sank 39.84%.
• Year by year, Treasury Shares stood at $21.5 million in 2022, then jumped by 1697.2% to $386.0 million in 2023, then sank by 34.75% to $251.8 million in 2024, then tumbled by 100.0% to $1465.0 in 2025.
• According to Business Quant data, Treasury Shares over the past three periods registered $1465.0, $251.8 million, and $251.8 million for Q4 2025, Q3 2024, and Q2 2024 respectively.